2y6n
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | ==STRUCTURE OF LINEAR GRAMICIDIN D OBTAINED USING TYPE I CRYSTALS GROWN IN A 8.8 MONOACYLGLYCEROL LIPID CUBIC PHASE.== | |
- | + | <StructureSection load='2y6n' size='340' side='right' caption='[[2y6n]], [[Resolution|resolution]] 1.26Å' scene=''> | |
- | + | == Structural highlights == | |
+ | <table><tr><td colspan='2'>[[2y6n]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Brevibacillus_brevis Brevibacillus brevis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2Y6N OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2Y6N FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=15P:POLYETHYLENE+GLYCOL+(N=34)'>15P</scene>, <scene name='pdbligand=P4C:O-ACETALDEHYDYL-HEXAETHYLENE+GLYCOL'>P4C</scene></td></tr> | ||
+ | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=DLE:D-LEUCINE'>DLE</scene>, <scene name='pdbligand=DVA:D-VALINE'>DVA</scene>, <scene name='pdbligand=ETA:ETHANOLAMINE'>ETA</scene>, <scene name='pdbligand=FVA:N-FORMYL-L-VALINE'>FVA</scene></td></tr> | ||
+ | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1nt6|1nt6]], [[1jo3|1jo3]], [[1alz|1alz]], [[1grm|1grm]], [[1jo4|1jo4]], [[1bdw|1bdw]], [[1nru|1nru]], [[1w5u|1w5u]], [[1tkq|1tkq]], [[1mag|1mag]], [[2izq|2izq]], [[1c4d|1c4d]], [[1av2|1av2]], [[1kqe|1kqe]], [[1mic|1mic]], [[1nt5|1nt5]], [[1al4|1al4]], [[1gmk|1gmk]], [[1ng8|1ng8]], [[1nrm|1nrm]], [[1jno|1jno]], [[1alx|1alx]], [[2xdc|2xdc]], [[2y5m|2y5m]]</td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2y6n FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2y6n OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2y6n RCSB], [http://www.ebi.ac.uk/pdbsum/2y6n PDBsum]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Gramicidin is an apolar pentadecapeptide antibiotic consisting of alternating D-and L-amino acids. It functions, in part, by creating pores in membranes of susceptible cells rendering them leaky to monovalent cations. The peptide should be able to traverse the host membrane either as a double stranded, intertwined double helix (DSDH) or as a head-to-head single stranded helix (HHSH). Current structure models are based on macromolecular X-ray crystallography (MX) and nuclear magnetic resonance (NMR). However, the HHSH form has only been observed by NMR. The shape and size of the different gramicidin conformations differ. We speculated therefore that reconstituting it into a lipidic mesophase with bilayers of different microstructures would preferentially stabilize one form over the other. By using such mesophases for in meso crystallogenesis the expectation was that at least one would generate crystals of gramicidin in the HHSH form for structure determination by MX. This was tested using commercial and in-house synthesised lipids that support in meso crystallogenesis. Lipid acyl chain lengths were varied from 14 to 18 carbons to provide mesophases with a range of bilayer thicknesses. Unexpectedly, all lipids produced high quality, structure-grade crystals with gramicidin only in the DSDH conformation. | ||
- | + | Membrane Protein Crystallization in Lipidic Mesophases. Hosting lipid affects on the crystallization and structure of a transmembrane peptide.,Hofer N, Aragao D, Lyons JA, Caffrey M Cryst Growth Des. 2011 Apr 6;11(4):1182-1192. Epub 2011 Feb 16. PMID:22933857<ref>PMID:22933857</ref> | |
- | + | ||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
==See Also== | ==See Also== | ||
*[[Gramicidin|Gramicidin]] | *[[Gramicidin|Gramicidin]] | ||
- | + | == References == | |
- | == | + | <references/> |
- | + | __TOC__ | |
+ | </StructureSection> | ||
[[Category: Brevibacillus brevis]] | [[Category: Brevibacillus brevis]] | ||
- | [[Category: Aragao, D | + | [[Category: Aragao, D]] |
- | [[Category: Caffrey, M | + | [[Category: Caffrey, M]] |
- | [[Category: Hoefer, N | + | [[Category: Hoefer, N]] |
[[Category: Antibiotic]] | [[Category: Antibiotic]] | ||
[[Category: Ion channel]] | [[Category: Ion channel]] | ||
[[Category: Mesophase]] | [[Category: Mesophase]] | ||
[[Category: Sponge phase]] | [[Category: Sponge phase]] |
Revision as of 18:02, 21 December 2014
STRUCTURE OF LINEAR GRAMICIDIN D OBTAINED USING TYPE I CRYSTALS GROWN IN A 8.8 MONOACYLGLYCEROL LIPID CUBIC PHASE.
|